- Encysive Pharmaceuticals Blind-Sided: Thelin Receives Approvable Letter from FDA
- FDA Delay of Tysabri Verdict Not a Surprise (BIIB, ELN)
- Nabi Biopharmaceuticals Continues Clinical Development of StaphVax (NABI)
- Tysabri Comes Out On Top At FDA Panel Meeting (BIIB, ELN)
- Tysabri To Be Discussed At FDA Advisory Committee Meeting: Findings From The Briefing Documents (BIIB, ELN)
BioBlogger is a contributor to Seeking Alpha.
This area is reserved for BioBlogger's:
- Trading frequency
Users can update their snapshots by editing their profiles via Settings.
Currently, there is no company profile for BioBlogger.
Currently, there are no blog details for BioBlogger.
Currently, there are no book details for BioBlogger.
Latest comments on BioBlogger's Articles
LATEST ARTICLES & INSTAPOSTS more »